Profile: Evera Medical, Inc. is a medical device company focused on developing & commercializing novel biomaterials for tissue reconstruction, repair and augmentation. Our implants are meant to provide strong support, yet mimic the compliant nature of human tissue. VeraMesh bioengineered tissue replacement is a dual-layer laminate. At its core is a novel, compliant, open-cell silicone foam matrix, with almost 90% empty space, which gives VeraMesh its tissue-like feel. A thin outer layer of expanded polytetrafluoroethylene (ePTFE), employed in a unique way, is meant to give VeraMesh mechanical integrity & to encourage tissue attachment to stabilize the implant, and vascular in-growth to minimize infection. The ePTFE outer layer is meant to elicit no foreign body response, thus preventing a fibrotic scar plate that could harden or shrink the implant. VeraMesh bioengineered tissue replacement provides mechanical support from the moment it is implanted. It encourages durable tissue regeneration while remaining compliant and conformable. It promotes strong, effective healing without excessive inflammation, encapsulation, foreign body reaction, or risk of infection, and permanently adds volume to tissue in applications where augmentation is desired.

The company was founded in 2004.